Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this clinical trial is to learn about INS018_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.
Epistemonikos ID: f57a465efde5c475e44df303052ad41450966422
First added on: May 15, 2024